Elevation of cytokines in peritoneal fluid and blood in patients with liver cirrhosis

Hepato-Gastroenterology

Volumn 51, Issue 56, 2004, Pages 505-509

  Eriksson, A S ^a   Gretzer, C ^b   Wallerstedt, S ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Ascites; Cytokines; Liver cirrhosis; Paracentesis

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; ASCITES FLUID; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNE SYSTEM; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MALE; PATHOGENESIS; PERITONEAL FLUID; PRIORITY JOURNAL; VIRUS HEPATITIS;

ADULT; AGED; ASCITES; ASCITIC FLUID; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; LIVER CIRRHOSIS; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1842430962     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Nanji AA, Zakim B: Hepatology. In: Zakim B (Ed.). A Textbook of Liver Disease, vol. 2, 3rd Edition. Philadelphia, PA: Saunders, 1996; pp. 891-962.
2. Marbet UA, Blanchi L, Meury U, et al: Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease. J Hepatol 1987; 4:364-372.
3. Triger DR, Wright R: Immunological aspects of liver disease I. In: Wright R, Millward-Sadler GH, Alberti KG, Karran S (Eds.). Liver and Biliary Disease, 2nd Edition. London: Balliere Tindall, 1985; pp. 215-231.
4. Vento S, Nouri-Aria KT, Eddlestone AL: Immune mechanisms in autoimmune chronic active hepatitis. Scand J Gastroenterol 1985; 20:114(Suppl):91-103.
5. Paronetto F: Cell-mediated immunity in liver disease. Hum Pathol 1986; 17:168-178.
6. Diez RA, Santos PJ, Lopez MG, et al: Tumour necrosis factor, interleukin-1 and interleukin-6 in alcoholic cirrhosis. Alcohol Alcohol 1993; 3:319-323.
7. Garcia-Gonzalez M, Boixeda D, Herrero D, et al: Effect of granulocyte-macrophage colony-stimulating factor on leukocyte function in cirrhosis. Gastroenterology 1993; 105:527-531.
8. Genesca J, Gonzalez A, Segura R, et al: Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis. Am J Gastroenterol 1999; 1:169-177.
9. Guarner C, Soriano G, Thommas A, et al: Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993; 18:1139-1143.
10. Le Moine O, Soupison T, Sogni P, et al: Plasma endotoxin and tumour necrosis factor-α in the hyperkinetic state of cirrhosis. J Hepatol 1995; 23:391-395.
11. Zhang P, Liang K, Yin C: Nitric oxide levels in cirrhotic patients. Chung Hua Nei Ko Tsa Chih 1997; 36:25-27.
12. Barak N, Zemel R, Ben-Ari Z, et al: Nitric oxide metabolites in decompensated liver cirrhosis. Dig Dis Sci 1999; 44:1338-1341.
13. Shimizu Y, Miayazaki M, Ito H, et al: Enhanced polymorphonuclear neutrophil-mediated endothelial cell injury and its relation to high surgical mortality rate in cirrhotic patients. Am J Gastroenterol 1999; 94:3297-3303.
14. Moore KW, O'Garra A, De Waal Malefyt R, et al: Interleukin-10. Ann Rev Immunol 1993; 11:165-190.
15. Dinarello CA: Biological basis for interleukin-1 in disease. Blood 1996; 87:2095-2147.
16. Albers I, Hartmann H, Bircher J, et al: Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand J Gastroenterol 1989; 24:269-276.
17. Devière J, Content J, Denys C, et al: Excessive bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology 1990; 11:628-634.
18. Khoruts A, Stahnke L, McClain CJ, et al: Circulating tumour necrosis factor, interleukin-1, and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991; 13:267-276.
19. Tilg H, Wilmer A, Vogel W, et al: Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992; 103:264-274.
20. Lee FY, Lu RH, Tsai YT, et al: Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumour necrosis factor-α and hyperdynamic circulation. Scand J Gastroenterol 1996; 31:500-505.
21. Fong Y, Marano MA, Moldawer LL, et al: The acute splanchnic and peripheral tissue metabolic response to endotoxin in human. J Clin Invest 1990; 85:1896-1904.
22. Kuhns DB, Alvord WG, Gallin JI: Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. J Infect Dis 1995; 171:145-152.
23. Sánchez-Rodríguez A, Criado M, Rodríguez- López AM, et al: Increased nitric oxide synthesis and inducible nitric oxides synthetase expression in patients with alcoholic and non-alcoholic liver cirrhosis. Clin Sci 1988; 94:637-643.
24. Gordon S: Biology of Macrophage. J Cell Sci 1986; 4:267-286.
25. Le Moine O, Marchant A, De Groote D, et al: Role of defective monocyte interleukin-10 release in tumour necrosis factor-alpha overproduction in alcohol cirrhosis. Hepatology 1995; 22:1436-1439.
26. Vallance P, Moncada S: Hyperdynamic circulation in cirrhosis: a role for nitric oxide. Lancet 1991; 337:776-778.
27. Laffi G, Foschi M, Masini E, et al: Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. Hepatology 1995; 22:1666-1673.
28. Ohkawa K, Ikeda V, Kawasaki K, et al: Inhibitory effect of interleukin-6 on vascular smooth muscle contraction. Am J Physiol 1994; 266:H898-902.
29. Kim DC, Retitz B, Carmichael DF, et al: Kidney as a major clearance organ for recombinant human interleukin-1 receptor antagonist. J Pharm Sci 1995; 84:575-580.
30. Deaciuc IV, Alappat JM, McDonaough KH, et al: Effect of chronic alcohol consumption by rats on tumour necrosis factor-alpha and interleukin-6 clearance in vivo and by the isolated perfused liver. Biochem Pharmacol 1996; 52:891-899.